Haemonetics Corporation (HAE)

Operating profit margin

		Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020
Operating income (ttm)	US$ in thousands	221,817	201,646	188,595	172,201	186,104	170,195	167,496	178,925	156,033	139,977	132,349	110,127	80,750	40,376	45,150	79,422	89,747	136,929	137,411	128,368
Revenue (ttm)	US$ in thousands	1,360,824	1,373,515	1,361,223	1,333,895	1,309,055	1,270,181	1,239,232	1,218,534	1,168,660	1,129,246	1,083,714	1,026,126	993,196	953,223	933,825	903,414	870,463	883,926	902,525	945,605
Operating profit margin		16.30%	14.68%	13.85%	12.91%	14.22%	13.40%	13.52%	14.68%	13.35%	12.40%	12.21%	10.73%	8.13%	4.24%	4.83%	8.79%	10.31%	15.49%	15.23%	13.58%

March 31, 2025 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $221,817K ÷ $1,360,824K
= 16.30%

Haemonetics Corporation's operating profit margin has shown some fluctuations over the period from June 30, 2020, to March 31, 2025. The margin started at 13.58% in June 2020, peaked at 15.49% in December 2020, then experienced a decline reaching 4.83% in September 2021. Over the subsequent quarters, the operating profit margin gradually recovered, showing an upward trend. By March 31, 2025, the operating profit margin had increased to 16.30%.

Overall, the trend in Haemonetics' operating profit margin appears to exhibit variability but with a general tendency towards improvement over the period analyzed. This indicates the company's ability to effectively manage its operating expenses and generate profits from its core business operations.